Gene therapy and spinal disorders

International Orthopaedics

Volumn 25, Issue 1, 2001, Pages 1-4

  Li, Haisheng ^a   Zou, Xuenong ^b   Bünger, Cody ^c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Zhuhai Medical Center   (China)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; MATRIX METALLOPROTEINASE INHIBITOR; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; RECOMBINANT TUMOR NECROSIS FACTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; GENE TARGETING; GENE THERAPY; HUMAN; INTERVERTEBRAL DISK DEGENERATION; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RETROVIRUS; REVIEW; SPINE DISEASE; SPINE FUSION;

FORECASTING; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HUMANS; LOW BACK PAIN; SPINAL CORD INJURIES; SPINAL DISEASES; SPINAL FUSION;

EID: 0035048934     PISSN: 03412695     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002640000207     Document Type: Review

References (35)

1. Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy
2. 1995 Volvo Award in basic sciences. The use of an osteoinductive growth factor for lumbar spinal fusion. Part II: Study of dose, carrier, and species
3. Video-assisted lateral intertransverse process arthrodesis. Validation of a new minimally invasive lumbar spinal fusion technique in the rabbit and nonhuman primate (rhesus) models
4. Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1)
5. Discs degenerate before facets
6. Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: A model of human osteogenesis imperfecta
7. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity
8. Stress fracture of the iliac bone with subfascial femoral neuropathy: Unusual complications at a bone graft donor site: Case report
9. Utilization of type I collagen gel, demineralized bone matrix, and bone morphogenetic protein-2 to enhance autologous bone lumbar spinal fusion
10. Muscular dystrophy: Identification and use of genes for diagnostics and therapeutics
11. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy
12. Morphology of the lumbar intertransverse process fusion mass in the rabbit model: A comparison between two bone graft materials - rhBMP-2 and autograft
13. Ex vivo gene delivery of platelet-derived growth factor increases 0-2A progenitors in adult rat spinal cord
14. Treatment with genetically engineered fibroblasts producing NGF or BDNF can accelerate recovery from traumatic spinal cord injury in the adult rat
15. Germline gene therapy?
16. The nerve growth factor 35 years later
17. Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats
18. Human gene therapy comes of age
19. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
20. Ossification of the ligamentum flavum induced by bone morphogenetic protein. An experimental study in mice
21. Adenovirus-mediated gene transfer to nucleus pulposus cells. Implications for the treatment of intervertebral disc degeneration
22. Induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model
23. Induction of bone in composites of osteogenin and porous hydroxyapatite in baboons
24. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements
25. Pseudarthrosis of the spine
26. The effect of osteogenin (a bone morphogenetic protein) on the formation of bone in orthotopic segmental defects in rats
27. Donor site pain from the ilium. A complication of lumbar spine fusion
28. Stimulation of mature canine intervertebral disc by growth factors
29. Nerve growth factor delivery by gene transfer induces differential outgrowth of sensory, motor, and noradrenergic neurites after adult spinal cord injury
30. Recombinant human bone morphogenetic protein induces bone formation
31. Transfer of genes to chondrocytic cells of the lumbar spine. Proposal for a treatment strategy of spinal disorders by local gene therapy
32. Meralgia paresthetica: A complication of iliac bone procurement
33. Morbidity at bone graft donor sites
34. A prospective, randomized study of lumbar fusion. Preliminary results
35. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2)